title: The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one-year follow-up.
abstract: The natural course of asymptomatic Chlamydia trachomatis infections in women was studied during one year in a cohort based nested case-control study. Healthy women (n = 744, from four company health services in Amsterdam) with a medical check-up prior to job engagement were included. C. trachomatis-positive women (n = 30, cases) and a randomly selected control group of C. trachomatis-negative women (n = 186, controls) were followed for one year. Urine specimens (at one, six and 12 months) were analysed for the presence of C. trachomatis-DNA and the C. trachomatis-serovars, and questionnaires were filled in. The C. trachomatis prevalence and natural course in relation to demographic and sexual characteristics after one, six and 12 months were studied. The main outcome measures were 1) the prevalence of C. trachomatis using urine specimens; 2) self-reported complaints; 3) clinical symptoms reported to the coordinating physicians. The prevalence of asymptomatic C. trachomatis infections was 4% and there was no correlation with demographic and sexual characteristics. The person/year clearance rate was 44.7% per year. None of the C. trachomatis-positive women developed clinical symptoms or used C. trachomatis specific antibiotic treatment. Women with or without an asymptomatic infection had the same number of self-reported urogenital complaints during follow-up. In persisting infections twice as many C. trachomatis-serovar E infections were detected as compared to clearing infections. Our findings showed that almost half of the asymptomatic C. trachomatis infections in women cleared during one year of follow-up and none developed clinical pelvic inflammatory disease (PID), which is a much lower figure than previously suggested. Therefore these data are important for cost effectiveness calculations in screening programmes for asymptomatic C. trachomatis infections.
authors.affiliation: Department of Pathology, Section of Molecular Pathology, Vrije Universiteit Medical Center, Amsterdam, The Netherlands.
authors.forename: Servaas A
authors.initials: SA
authors.lastname: Morré
authors.forename: Adriaan J C
authors.initials: AJ
authors.lastname: van den Brule
authors.forename: Lawrence
authors.initials: L
authors.lastname: Rozendaal
authors.forename: A Joan P
authors.initials: AJ
authors.lastname: Boeke
authors.forename: Feja J
authors.initials: FJ
authors.lastname: Voorhorst
authors.forename: Sjoerd
authors.initials: S
authors.lastname: de Blok
authors.forename: Chris J L M
authors.initials: CJ
authors.lastname: Meijer
mesh_terms: D016022:Case-Control Studies; D002584:Cervix Uteri / Q000382:microbiology*; D002690:Chlamydia Infections / Q000191:economics / Q000453:epidemiology / Q000382:microbiology / Q000473:pathology*; D002692:Chlamydia trachomatis / Q000235:genetics / Q000276:immunology / Q000302:isolation & purification*; D015331:Cohort Studies; D019937:Diagnostic Techniques and Procedures / Q000592:standards; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008403:Mass Screening / Q000592:standards; D011795:Surveys and Questionnaires; D014556:Urine / Q000382:microbiology